Current therapeutic options targeting symptoms of chronic rhinosinusitis in CF include topical steroid treatment, topical antibiotic delivery, surgical intervention, and increasing reliance on CFTR modulator therapies, though there is not yet strong agreement for how to utilize all of these treatment options amongst PwCF [68,69,70]. The gene discussed is CFTR; the disease is chronic rhinosinusitis.